1. Home
  2. VATE vs FBIO Comparison

VATE vs FBIO Comparison

Compare VATE & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$11.76

Market Cap

110.8M

Sector

Industrials

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$2.70

Market Cap

111.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VATE
FBIO
Founded
1994
2006
Country
United States
United States
Employees
N/A
78
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
111.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
VATE
FBIO
Price
$11.76
$2.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
88.5K
694.0K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,246,000,000.00
N/A
Revenue This Year
N/A
$55.22
Revenue Next Year
N/A
$40.55
P/E Ratio
N/A
N/A
Revenue Growth
12.55
N/A
52 Week Low
$3.75
$1.83
52 Week High
$21.30
$4.53

Technical Indicators

Market Signals
Indicator
VATE
FBIO
Relative Strength Index (RSI) 29.56 37.51
Support Level $4.38 $2.31
Resistance Level $13.40 $2.94
Average True Range (ATR) 0.74 0.20
MACD 0.14 -0.10
Stochastic Oscillator 9.86 14.56

Price Performance

Historical Comparison
VATE
FBIO

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Share on Social Networks: